peptides

Fitness audiences are buzzing about peptides, with content about the substances drawing millions of views and likes. The discussion centres on peptides' growing popularity in bodybuilding and performance circles, where they are promoted for muscle growth and recovery despite limited regulation and unclear long-term safety. Commenters appear divided between enthusiasm for perceived results and caution about unproven claims and health risks.

Ancient Nutrition is promoting a strawberry-flavored Grass Fed Multi Protein powder sold through Whole Foods Market. The blend combines grass-fed whey, bone broth, collagen peptides, colostrum and probiotics, delivering 26 grams of protein per serving across 15 servings per container. It is marketed as supporting joint and gut health, fitting the growing consumer interest in collagen and bone broth supplements.

B7-33, a relaxin-family peptide analogue studied for its biased signaling properties, is being highlighted as an example of how biased ligand research is expanding in pharmacology. Researchers interested in compounds that activate beneficial pathways while avoiding unwanted ones are citing B7-33 as a case study in designing drugs with fewer side effects. Discussion centers on its potential in fibrosis and cardiovascular research.

ETF Trends is hosting a webcast titled 'Accessing the peptide economy', examining how investors can gain exposure to companies involved in peptide-based drugs and related biotechnology. The session is expected to cover market opportunities, thematic exchange-traded funds and the growing commercial role of peptide therapeutics in healthcare investing.

A Georgia newspaper has published a feature examining TB-500, a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, and its place in regenerative medicine. The piece explores the science behind the compound and the growing interest in peptide-based approaches to tissue repair and recovery.